1-10 of 288 results

What the recent surge in IP filings means for your business
Insight 10 Sep 2024

In this Insight, we summarise the Report findings and highlight key factors for businesses to consider in managing their IP risks and IP opportunities. ...

IP Australia announces changes to fees
Insight 05 Sep 2024

IP Australia has announced sweeping changes to the amount and timing of official fees for patents, trade marks, designs and plant breeders' rights, as well as changes to fees and recoverable costs for oppositions. The changes will come into effect 1 October 2024. ...

InIP: What's happening in intellectual property - July 2024
Insight 15 Aug 2024

Your regular wrap-up of some of the world's leading and intriguing IP stories. ...

What's happening in intellectual property - April 2024
Insight 29 Apr 2024

Your regular wrap-up of some of the world's leading and intriguing IP stories. ...

Patentability of computer-implemented inventions remains unclear
Insight 27 Mar 2024

In this Insight, we unpack Justice Burley's reasoning for the approach taken and consider where this latest judgment (Aristocrat Technologies Australia Pty Limited v Commissioner of Patents (No 3) [2024] FCA 212) leaves us on this topical issue. ...

InIP: What's happening in intellectual property - February 2024
Insight 29 Feb 2024

Your regular wrap-up of some of the world's leading and intriguing IP stories. ...

InIP: What's happening in intellectual property - December 2023
Insight 14 Dec 2023

Your regular wrap-up of some of the world's leading and intriguing IP stories. ...

InIP: What's happening in intellectual property - November 2023
Insight 03 Nov 2023

Your regular wrap-up of some of the world's leading and intriguing IP stories. ...

InIP: What's happening in intellectual property - August 2023
Insight 31 Aug 2023

Your regular wrap-up of some of the world's leading and intriguing IP stories. ...

Australian Government takes its $325 million damages claim to the High Court in Commonwealth v Sanofi
Insight 30 Aug 2023

The Full Court has confirmed that the Australian Government is not entitled to any damages from Sanofi and Bristol-Myers Squibb. In this Insight, we examine the appeal decision and consider its implications for patent infringement proceedings relating to pharmaceutical products. ...

Refine

From
To